Dear participants,

I would like to warmly welcome you to the CME CVS conference in Athens. Actavis, the main partner of this education, is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, branded generic, Over-the Counter (OTC) and biosimilar products. The successful integration of a number of acquisitions has helped Actavis to gain 3rd position among the generic companies worldwide.

Founded in 1956, the Group is operating in over 60 countries around the globe. Actavis invests heavily in research and development, as well as in the education of healthcare professionals. An example of this activity will take place in the following days.

I believe that this educational event will contribute to improving the healthcare in all countries concerned, and would like to wish you a fruitful meeting with inspiring lectures and motivating discussions.

With best regards,

Petr Kozel
Vice President, Generics and RX – Commercial, Europe and MEAAP



Athens, June 5-6, 2015

4th CME CVS 2014

Summary, lectures, archive


Live streaming and an online archive of the International Postgraduate Schools

Live Broadcasting